Liver-spleen infarcts following transcatheter chemoembolization: a case report and review of the literature on adverse effects.
Cohen
S E
SE
Department of Internal Medicine, Hadassah University Hospital-Ein Karem, Jerusalem, Israel.
Safadi
R
R
Verstandig
A
A
Eid
A
A
Sasson
T
T
Symmer
L
L
Shouval
D
D
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D006528:Carcinoma, Hepatocellular / Q000000981:diagnostic imaging / Q000628:therapy*; D016461:Chemoembolization, Therapeutic / Q000009:adverse effects*; D003287:Contrast Media; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007238:Infarction / Q000000981:diagnostic imaging / Q000209:etiology*; D007459:Iodized Oil; D008099:Liver / Q000098:blood supply*; D008100:Liver Abscess / Q000000981:diagnostic imaging / Q000209:etiology; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000628:therapy*; D013159:Splenic Infarction / Q000000981:diagnostic imaging / Q000209:etiology*; D014057:Tomography, X-Ray Computed
D000903:Antibiotics, Antineoplastic; D003287:Contrast Media; D007459:Iodized Oil; D004317:Doxorubicin